Surgical Results of Growth Hormone-Secreting Pituitary Adenoma.
10.3340/jkns.2009.45.5.271
- Author:
Min Su KIM
1
;
Hyun Dong JANG
;
Oh Lyong KIM
Author Information
1. Department of Neurosurgery, Yeungnam University College of Medicine, Daegu, Korea. olkim@med.yu.ac.kr
- Publication Type:Original Article
- Keywords:
Growth hormone-secreting pituitary adenoma;
Cavernous sinus;
Remission induction
- MeSH:
Acromegaly;
Cavernous Sinus;
Female;
Follow-Up Studies;
Growth Hormone;
Growth Hormone-Secreting Pituitary Adenoma;
Humans;
Male;
Pituitary Neoplasms;
Remission Induction;
Retrospective Studies
- From:Journal of Korean Neurosurgical Society
2009;45(5):271-274
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: We retrospectively analyzed the surgical outcomes of 42 patients with growth hormone (GH)-secreting pituitary adenoma to evaluate the clinical manifestations and to determine which preoperative factors that significantly influence the remission. METHODS: Forty-two patients with GH-secreting pituitary adenoma underwent transsphenoidal surgery (TSS) between 1995 and 2007. The patient group included 23 women and 19 men, with a mean age of 40.2 (range 13-61) years, and a mean follow-up duration of 49.4 (range 3-178) months after the operation. For comparable radiological criteria, we classified parasellar growth into five grades according to the Knosp classification. We analyzed the surgical results of the patients according to the most recent stringent criteria for cure. RESULTS: The overall rate of endocrinological remission in the group of 42 patients after primary TSS was 64% (26 of 42). The remission rate was 67% (8 of 12) for microadenoma and 60% (18 of 30) for macroadenoma. The remission rate was 30% (3 of 10) for the group with cavernous sinus invasion and 72% (23 of 32) for the group with intact cavernous sinus. Cavernous sinus invasion in Knosp grade III and IV was significantly correlated with the remission rate. There was a significant relationship between preoperative mean GH concentration and early postoperative outcome, with most patients in remission having a lower preoperative GH concentration. CONCLUSION: TSS is thought to be an effective primary treatment for GH-secreting pituitary adenomas according to the most recent criteria of cure. Because the remission rate in cases with cavernous sinus invasion is very low, early detection of the tumor before it extends into the cavernous sinus and a long-term endocrinological and radiological follow-up are necessary in order to improve the remission rate of acromegaly.
